VORBEUGUNG ODER BEHANDLUNG VON HARNSÄURE- ODER GICHTERKRANKUNG

Patent europeic · EP3251675 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3251675
Numer da la dumonda
EP16742632
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-01-2016
Publitgà
06-12-2017
Concedì
21-04-2021
La protecziun finescha il pli tard
27-01-2036
Proxima taxa annuala scadenta
31-01-2027
Classas IPC
C07D 473/08 (2006.01)
C07D 473/06 (2006.01)
A61K 31/522 (2006.01)
A61P 13/04 (2006.01)
A61P 19/06 (2006.01)
A61P 29/00 (2006.01)
A61P 19/02 (2006.01)
A61P 13/12 (2006.01)
Prioritad
CN 201510048096 30.01.2015
CN 201510079809 13.02.2015
CN 201510080714 13.02.2015
CN 201510216089 30.04.2015
Dumonda PCT
PCT/CN2016/000061 28.01.2016
Publicaziun PCT
WO2016/119570 04.08.2016
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-10-2026

    Adressa dal represchentant midada

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 20.10.2026

  2. 01-02-2026

    Next annual fee due on

    Next annual fee due on
    31.01.2026 → 31.01.2027

    Published in Swissreg on 01.02.2026

  3. 29-01-2026

    Adressa dal possessur midada

    Owner
    Shanton Pharma Pte. Ltd., 80 Robinson Road 02-00, Singapore 068898, Singapore → Shanton Pharma Pte. Ltd., 168 Robinson Road, # 13-05, Capital Tower, Singapore 068912, Singapore

    Published in Swissreg on 29.01.2026

  4. 01-02-2025

    Next annual fee due on

    Next annual fee due on
    31.01.2025 → 31.01.2026

    Published in Swissreg on 01.02.2025

  5. 01-02-2024

    Midada

    Published in Swissreg on 01.02.2024

  6. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  7. 02-03-2022

    Midada

    Published in Swissreg on 02.03.2022

  8. 05-06-2021

    Represchentant inscrit

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 05.06.2021

1 endataziun pli veglia
  1. 21-04-2021

    Concedì

    Published in Swissreg on 21.04.2021

Partidas

Possessur

Shanton Pharma Pte. Ltd.

168 Robinson Road, # 13-05 Capital Tower, Singapore 068912, SG

Represchentant

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

Inventur

LIU, Jinrong

Jinan Shandong 250101, CN

HUANG, Zhenhua

Jinan Shandong 250101, CN

ZHANG, Qian

Jinan Shandong 250101, CN

CHI, Shuangshuang

Jinan Shandong 250101, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.